| Literature DB >> 31831552 |
Anthony William Gilbert1,2, Jeremy Jones2, Maria Stokes2, Emmanouil Mentzakis3, Carl R May4.
Abstract
INTRODUCTION: Technology has been placed at the centre of global health policy and has been cited as having the potential to increase efficiency and remove geographical boundaries for patients to access care. Communication technology may support patients with orthopaedic problems, which is one of the leading causes of disability worldwide. There are several examples of technology being used in clinical research, although uptake in practice remains low. An understanding of patient preferences will support the design of a communication technology supported treatment pathway for patients undergoing orthopaedic rehabilitation. METHODS AND ANALYSIS: This mixed methods project will be conducted in four phases. In phase I, a systematic review of qualitative studies reporting communication technology use for orthopaedic rehabilitation will be conducted to devise a taxonomy of tasks patients' face when using these technologies to access their care. In phase II, qualitative interviews will investigate how the work of being a patient changes during face-to-face and communication technology consultations and how these changes influence preference. In phase III, a discrete choice experiment will investigate the factors that influence preferences for the use of communication technology for orthopaedic rehabilitation consultations. Phase IV will be a practical application of these results. We will design a 'minimally disruptive' communication technology supported pathway for patients undergoing orthopaedic rehabilitation. ETHICS AND DISSEMINATION: The design of a pathway and underpinning patient preference will assist in understanding factors that might influence technology implementation for clinical care. This study requires ethical approval for phases II, III and IV. Approvals have been received for phase II (approval received on 4 December 2016 from the South Central-Oxford C Research Ethics Committee (IRAS ID: 255172, REC Reference 18/SC/0663)) and phase III (approval received on 18 October 2019 from the London-Hampstead Research Ethics Committee (IRAS ID: 248064, REC Reference 19/LO/1586)) and will be sought for phase IV. All participants will provide informed written consent prior to being enrolled onto the study. PROSPERO REGISTRATION NUMBER: CRD42018100896. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.Entities:
Keywords: Adult orthopaedics; Musculoskeletal disorders; Telemedicine
Mesh:
Year: 2019 PMID: 31831552 PMCID: PMC6924859 DOI: 10.1136/bmjopen-2019-035210
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Overview of the CONNECT project.
Eligibility criteria of studies
| Inclusion | Exclusion |
|
Full-text academic papers. Patients with an orthopaedic/musculoskeletal problem. Studies reporting patients accessing physical assessment/rehabilitation using communication technology (eg, telephone, videoconferencing) in an orthopaedic/musculoskeletal setting. Qualitative studies or studies with a qualitative component that focuses on the patient viewpoint of accessing communication technology. |
Conference abstracts. Participants without an orthopaedic/musculoskeletal complaint. Quantitative studies. Studies not reporting patient viewpoints. |
Inclusion/exclusion criteria for phase II
| Inclusion | Exclusion |
|
Patients, over the age of 18 years, attending the hospital site for physiotherapy or occupational therapy. Patients who have experience of orthopaedic/musculoskeletal condition. Patients who are able to provide informed written consent to enter into the study. Patients able to understand and speak English or a language covered by the hospitals interpreter service |
Patients without the capacity to consent. Patients suffering from disorders other than orthopaedic as the primary cause (eg, neurological or oncology disorders). |
Inclusion/exclusion criteria for phase III
| Inclusion | Exclusion |
|
Patients, over the age of 18 years, attending either hospital site for physiotherapy or occupational therapy. Patients who have experience of orthopaedic/musculoskeletal condition. Patients who are able to provide informed written consent to enter into the study. Patients able to understand and speak English or a language covered by the hospitals interpreter service. |
Patients without the capacity to consent. Patients suffering from disorders other than orthopaedic as the primary cause (eg, neurological or oncology disorders). |